drugset / Trial / NCT02589678
Zambia SiVET MMR Tdap-IPV
Phase 1/2
Completed
160 enrolled
Emory University
International AIDS Vaccine Initiative · collabZambia-Emory HIV Research Project · collab
RandomizedCrossoverTriple-blindScreening
Summary
Participants will receive vaccination for measles, mumps, and rubella (MMR) and tetanus, diphtheria, pertussis, and inactivated polio (Tdap-IPV). The study schedule design is to simulate a vaccine efficacy trial to see if single women can participate in studies that mimic actual HIV vaccine studies.
Timeline
- Start
- 2015-08
- Primary completion
- 2017-05-16
- Completion
- 2017-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MMR vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | TDaP-IPV vaccine | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.